Correction: E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615))

Valentina Montagnani; Luisa Maresca; Alessandro Apollo; Sara Pepe; Ryan M. Carr; Martin E. Fernandez-Zapico; Barbara Stecca

doi:10.1016/j.jbc.2023.104580

Correction: E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615))

Valentina Montagnani, Luisa Maresca, Alessandro Apollo, Sara Pepe, Ryan M. Carr, Martin E. Fernandez-Zapico, Barbara Stecca

Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The Funding and additional information section should read as follows: Funding and additional information-This work was supported by Institute for Cancer Research, Prevention and Clinical Network (ISPRO) funding, by a grant from the Italian Association for Cancer Research (AIRC; IG-23091 to B. S.) and by postdoctoral fellowships from AIRC n. 19580 (to V. M.) and n. 22644 (to L. M.).

Original language	English (US)
Article number	104580
Journal	Journal of Biological Chemistry
Volume	299
Issue number	3
DOIs	https://doi.org/10.1016/j.jbc.2023.104580
State	Published - Mar 2023

ASJC Scopus subject areas

Biochemistry
Molecular Biology
Cell Biology

Access to Document

10.1016/j.jbc.2023.104580

Fingerprint

Dive into the research topics of 'Correction: E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615))'. Together they form a unique fingerprint.

Cite this

Montagnani, V., Maresca, L., Apollo, A., Pepe, S., Carr, R. M., Fernandez-Zapico, M. E., & Stecca, B. (2023). Correction: E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615)). Journal of Biological Chemistry, 299(3), Article 104580. https://doi.org/10.1016/j.jbc.2023.104580

Correction: E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615)). / Montagnani, Valentina; Maresca, Luisa; Apollo, Alessandro et al.
In: Journal of Biological Chemistry, Vol. 299, No. 3, 104580, 03.2023.

Research output: Contribution to journal › Comment/debate › peer-review

Montagnani, V, Maresca, L, Apollo, A, Pepe, S, Carr, RM, Fernandez-Zapico, ME & Stecca, B 2023, 'Correction: E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615))', Journal of Biological Chemistry, vol. 299, no. 3, 104580. https://doi.org/10.1016/j.jbc.2023.104580

Montagnani V, Maresca L, Apollo A, Pepe S, Carr RM, Fernandez-Zapico ME et al. Correction: E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615)). Journal of Biological Chemistry. 2023 Mar;299(3):104580. doi: 10.1016/j.jbc.2023.104580

Montagnani, Valentina ; Maresca, Luisa ; Apollo, Alessandro et al. / Correction : E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615)). In: Journal of Biological Chemistry. 2023 ; Vol. 299, No. 3.

@article{2638e245eaac4b609413e6c043a0f896,

title = "Correction: E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615))",

abstract = "The Funding and additional information section should read as follows: Funding and additional information-This work was supported by Institute for Cancer Research, Prevention and Clinical Network (ISPRO) funding, by a grant from the Italian Association for Cancer Research (AIRC; IG-23091 to B. S.) and by postdoctoral fellowships from AIRC n. 19580 (to V. M.) and n. 22644 (to L. M.).",

author = "Valentina Montagnani and Luisa Maresca and Alessandro Apollo and Sara Pepe and Carr, {Ryan M.} and Fernandez-Zapico, {Martin E.} and Barbara Stecca",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors",

year = "2023",

month = mar,

doi = "10.1016/j.jbc.2023.104580",

language = "English (US)",

volume = "299",

journal = "Journal of Biological Chemistry",

issn = "0021-9258",

publisher = "American Society for Biochemistry and Molecular Biology Inc.",

number = "3",

}

TY - JOUR

T1 - Correction

T2 - E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615))

AU - Montagnani, Valentina

AU - Maresca, Luisa

AU - Apollo, Alessandro

AU - Pepe, Sara

AU - Carr, Ryan M.

AU - Fernandez-Zapico, Martin E.

AU - Stecca, Barbara

PY - 2023/3

Y1 - 2023/3

N2 - The Funding and additional information section should read as follows: Funding and additional information-This work was supported by Institute for Cancer Research, Prevention and Clinical Network (ISPRO) funding, by a grant from the Italian Association for Cancer Research (AIRC; IG-23091 to B. S.) and by postdoctoral fellowships from AIRC n. 19580 (to V. M.) and n. 22644 (to L. M.).

AB - The Funding and additional information section should read as follows: Funding and additional information-This work was supported by Institute for Cancer Research, Prevention and Clinical Network (ISPRO) funding, by a grant from the Italian Association for Cancer Research (AIRC; IG-23091 to B. S.) and by postdoctoral fellowships from AIRC n. 19580 (to V. M.) and n. 22644 (to L. M.).

UR - http://www.scopus.com/inward/record.url?scp=85149839830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149839830&partnerID=8YFLogxK

U2 - 10.1016/j.jbc.2023.104580

DO - 10.1016/j.jbc.2023.104580

M3 - Comment/debate

AN - SCOPUS:85149839830

SN - 0021-9258

VL - 299

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

IS - 3

M1 - 104580

ER -

Correction: E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis (Journal of Biological Chemistry (2020) 295(47) (16058–16071), (S0021925817504317), (10.1074/jbc.RA120.014615))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this